Guaifenesin

愈创甘油醚

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameGuaifenesin
Drug Alias Name愈创木酚甘油醚Guaiphenesinglyceryl guaiacolateHustosillRobitussin
ClassificationSmall molecules
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsCoughRhinitisCommon Cold +[4] 
Global Approved IndicationsCough
Approved Indications in ChinaCough
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomBrazil +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesRB Health US LLCDainippon Sumitomo Pharma Co LtdThe Central Pharmaceutical Co Ltd
Inactive CompaniesReckitt Benckiser IncReckitt Benckiser LlcVirginia Commonwealth University +[6] 
Active IndicationsCough
Inactive IndicationsRhinitisCommon ColdRespiratory Tract Infections

Other Information

ATC CodeR05CA03
Related LinksWikipediaDrugBankKEGG